These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33827266)

  • 1. A composite risk model predicts disease progression in early stages of COVID-19: A propensity score-matched cohort study.
    Xu J; Gao Y; Hu S; Li S; Wang W; Wu Y; Su Z; Zhou X; Cheng X; Zheng Q
    Ann Clin Biochem; 2021 Sep; 58(5):434-444. PubMed ID: 33827266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of neutrophil-to-lymphocyte ratio, lactate dehydrogenase, D-dimer, and computed tomography score in patients with coronavirus disease 2019.
    Cai YQ; Zhang XB; Zeng HQ; Wei XJ; Hu L; Zhang ZY; Ming Q; Peng QP; Chen LD
    Aging (Albany NY); 2021 Sep; 13(17):20896-20905. PubMed ID: 34495869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-6-based mortality risk model for hospitalized patients with COVID-19.
    Laguna-Goya R; Utrero-Rico A; Talayero P; Lasa-Lazaro M; Ramirez-Fernandez A; Naranjo L; Segura-Tudela A; Cabrera-Marante O; Rodriguez de Frias E; Garcia-Garcia R; Fernández-Ruiz M; Aguado JM; Martinez-Lopez J; Lopez EA; Catalan M; Serrano A; Paz-Artal E
    J Allergy Clin Immunol; 2020 Oct; 146(4):799-807.e9. PubMed ID: 32710975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of neutrophil-to-lymphocyte ratio in the classification diagnosis of coronavirus disease 2019].
    Fei M; Tong F; Tao X; Wang J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 May; 32(5):554-558. PubMed ID: 32576346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage.
    Liu J; Liu Y; Xiang P; Pu L; Xiong H; Li C; Zhang M; Tan J; Xu Y; Song R; Song M; Wang L; Zhang W; Han B; Yang L; Wang X; Zhou G; Zhang T; Li B; Wang Y; Chen Z; Wang X
    J Transl Med; 2020 May; 18(1):206. PubMed ID: 32434518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil-to-lymphocyte ratio, a critical predictor for assessment of disease severity in patients with COVID-19.
    Liu L; Zheng Y; Cai L; Wu W; Tang S; Ding Y; Liu W; Kou G; Xiong Z; Wang S; Zheng S
    Int J Lab Hematol; 2021 Apr; 43(2):329-335. PubMed ID: 33099889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new haematocytometric index: Predicting severity and mortality risk value in COVID-19 patients.
    Kilercik M; Demirelce Ö; Serdar MA; Mikailova P; Serteser M
    PLoS One; 2021; 16(8):e0254073. PubMed ID: 34351940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Predictive value of neutrophil/lymphocyte ratio on myocardial injury in severe COVID-19 patients].
    Chen Y; Wang KJ; Luo YC; Wang BZ; Zhang MM; Xu YQ; Yang YN; Ma YT
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):572-579. PubMed ID: 32842269
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic implications of neutrophil-lymphocyte ratio in COVID-19.
    Jimeno S; Ventura PS; Castellano JM; García-Adasme SI; Miranda M; Touza P; Lllana I; López-Escobar A
    Eur J Clin Invest; 2021 Jan; 51(1):e13404. PubMed ID: 32918295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
    Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
    JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CURB-65 may serve as a useful prognostic marker in COVID-19 patients within Wuhan, China: a retrospective cohort study.
    Guo J; Zhou B; Zhu M; Yuan Y; Wang Q; Zhou H; Wang X; Lv T; Li S; Liu P; Yang Y; He P; Zhang P
    Epidemiol Infect; 2020 Oct; 148():e241. PubMed ID: 32998791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19.
    Ye W; Chen G; Li X; Lan X; Ji C; Hou M; Zhang D; Zeng G; Wang Y; Xu C; Lu W; Cui R; Cai Y; Huang H; Yang L
    Respir Res; 2020 Jul; 21(1):169. PubMed ID: 32620118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of the neutrophil-to-lymphocyte ratio and C-reactive protein level for coronavirus disease 2019 (COVID-19).
    Yufei Y; Mingli L; Xuejiao L; Xuemei D; Yiming J; Qin Q; Hui S; Jie G
    Scand J Clin Lab Invest; 2020 Nov; 80(7):536-540. PubMed ID: 32804580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of the neutrophil to lymphocyte ratio for disease deterioration and serious adverse outcomes in patients with COVID-19: a prospective cohort study.
    Zeng ZY; Feng SD; Chen GP; Wu JN
    BMC Infect Dis; 2021 Jan; 21(1):80. PubMed ID: 33461497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19.
    Liu Y; Du X; Chen J; Jin Y; Peng L; Wang HHX; Luo M; Chen L; Zhao Y
    J Infect; 2020 Jul; 81(1):e6-e12. PubMed ID: 32283162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics of chronic liver disease with coronavirus disease 2019 (COVID-19): a cohort study in Wuhan, China.
    Li C; Chen Q; Wang J; Lin H; Lin Y; Lin J; Peng F; Chen J; Yang Z
    Aging (Albany NY); 2020 Aug; 12(16):15938-15945. PubMed ID: 32855361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biochemical analysis between common type and critical type of COVID-19 and clinical value of neutrophil/lymphocyte ratio].
    Li H; Zhao M; Xu Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jul; 40(7):965-971. PubMed ID: 32895161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study.
    Zheng Y; Zhang Y; Chi H; Chen S; Peng M; Luo L; Chen L; Li J; Shen B; Wang D
    Clin Chem Lab Med; 2020 Jun; 58(7):1106-1115. PubMed ID: 32352397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for illness severity in patients with COVID-19 pneumonia: a prospective cohort study.
    Zhang N; Zhang H; Tang Y; Zhang H; Ma A; Xu F; Sun Y; Jiang L; Shan F
    Int J Med Sci; 2021; 18(4):921-928. PubMed ID: 33456349
    [No Abstract]   [Full Text] [Related]  

  • 20. Usefulness of biological markers in the early prediction of corona virus disease-2019 severity.
    Bennouar S; Bachir Cherif A; Kessira A; Hamel H; Boudahdir A; Bouamra A; Bennouar D; Abdi S
    Scand J Clin Lab Invest; 2020 Dec; 80(8):611-618. PubMed ID: 32945705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.